Sala, Monera .

HRN: 24-43-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
CEFUROXIME 750MG (VIAL)
07/12/2024
07/13/2024
IV
1.5g
Q8
Pelvic Lap
Rejected 
07/17/2024
CEFUROXIME 500MG (TAB)
07/17/2024
07/24/2024
PO
1 Tab
BID
SP PELVIC LAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: